Articles | Volume 4, issue 1
Primate Biol., 4, 131–142, 2017
https://doi.org/10.5194/pb-4-131-2017

Special issue: Special diseases of nonhuman primates

Primate Biol., 4, 131–142, 2017
https://doi.org/10.5194/pb-4-131-2017

Review article 30 Jun 2017

Review article | 30 Jun 2017

Use of nonhuman primates in obstructive lung disease research – is it required?

Franziska Dahlmann and Katherina Sewald

Related subject area

Immunology
Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis
Bert A. 't Hart
Primate Biol., 6, 17–58, https://doi.org/10.5194/pb-6-17-2019,https://doi.org/10.5194/pb-6-17-2019, 2019
Short summary
The common marmoset (Callithrix jacchus): a relevant preclinical model of human (auto)immune-mediated inflammatory disease of the brain
Bert A. 't Hart, Jordon Dunham, S. Anwar Jagessar, and Yolanda S. Kap
Primate Biol., 3, 9–22, https://doi.org/10.5194/pb-3-9-2016,https://doi.org/10.5194/pb-3-9-2016, 2016
Short summary

Cited articles

Akdis, C. A.: Therapies for allergic inflammation: refining strategies to induce tolerance, Nat. Med., 18, 736–749, https://doi.org/10.1038/nm.2754, 2012.
Ayanoglu, G., Desai, B., Fick, R. B., Jr., Grein, J., de Waal Malefyt, R., Mattson, J., McClanahan, T., Olmstead, S., Reece, S. P., Van Scott, M. R., and Wardle, R. L.: Modelling asthma in macaques: longitudinal changes in cellular and molecular markers, Eur. Respir. J., 37, 541–552, https://doi.org/10.1183/09031936.00047410, 2011.
Barnes, P. J.: Inflammatory mechanisms in patients with chronic obstructive pulmonary disease, J. Allergy Clin. Immun., 138, 16–27, https://doi.org/10.1016/j.jaci.2016.05.011, 2016.
Beck, A., Wurch, T., Bailly, C., and Corvaia, N.: Strategies and challenges for the next generation of therapeutic antibodies, Nat. Rev. Immunol., 10, 345–352, https://doi.org/10.1038/nri2747, 2010.
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., and Pavord, I. D.: Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma, N. Engl. J. Med., 371, 1189–1197, https://doi.org/10.1056/NEJMoa1403291, 2014.